25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Clearside Biomedical Inc.
Buy, Hold or Sell?

Let's analyze Clearside Biomedical Inc. together

I guess you are interested in Clearside Biomedical Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Clearside Biomedical Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Clearside Biomedical Inc.

I send you an email if I find something interesting about Clearside Biomedical Inc..

1. Quick Overview

1.1. Quick analysis of Clearside Biomedical Inc. (30 sec.)










1.2. What can you expect buying and holding a share of Clearside Biomedical Inc.? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.19
Expected worth in 1 year
€-1.48
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
€-1.29
Return On Investment
-172.9%

For what price can you sell your share?

Current Price per Share
€0.75
Expected price per share
€0.615 - €1.19
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Clearside Biomedical Inc. (5 min.)




Live pricePrice per Share (EOD)
€0.75
Intrinsic Value Per Share
€-2.52 - €4.94
Total Value Per Share
€-2.71 - €4.75

2.2. Growth of Clearside Biomedical Inc. (5 min.)




Is Clearside Biomedical Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?-$15.9m$10.6m-$26.5m-166.7%

How much money is Clearside Biomedical Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$32.4m-$32.9m$461.9k1.4%
Net Profit Margin-394.9%-2,482.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Clearside Biomedical Inc. (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#886 / 917

Most Revenue
#441 / 917

Most Profit
#480 / 917

Most Efficient
#789 / 917
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Clearside Biomedical Inc.?

Welcome investor! Clearside Biomedical Inc.'s management wants to use your money to grow the business. In return you get a share of Clearside Biomedical Inc..

First you should know what it really means to hold a share of Clearside Biomedical Inc.. And how you can make/lose money.

Speculation

The Price per Share of Clearside Biomedical Inc. is €0.745. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clearside Biomedical Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clearside Biomedical Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.19. Based on the TTM, the Book Value Change Per Share is €-0.32 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clearside Biomedical Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.43-57.5%-0.43-57.5%-0.43-58.3%-0.30-40.4%-0.43-58.1%
Usd Book Value Change Per Share-0.35-46.9%-0.35-46.9%-0.36-48.4%-0.10-14.0%-0.03-4.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.35-46.9%-0.35-46.9%-0.36-48.4%-0.10-14.0%-0.03-4.7%
Usd Price Per Share1.14-1.14-1.09-1.90-1.74-
Price to Earnings Ratio-2.66--2.66--2.51-101.17-84.16-
Price-to-Total Gains Ratio-3.26--3.26--3.02--14.78--11.79-
Price to Book Ratio-5.43--5.43-7.80-8.50-7.61-
Price-to-Total Gains Ratio-3.26--3.26--3.02--14.78--11.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8086975
Number of shares1236
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.35-0.10
Usd Total Gains Per Share-0.35-0.10
Gains per Quarter (1236 shares)-432.16-128.84
Gains per Year (1236 shares)-1,728.63-515.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1729-17390-515-525
20-3457-34680-1031-1040
30-5186-51970-1546-1555
40-6915-69260-2061-2070
50-8643-86550-2577-2585
60-10372-103840-3092-3100
70-12100-121130-3608-3615
80-13829-138420-4123-4130
90-15558-155710-4638-4645
100-17286-173000-5154-5160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.05.00.016.7%1.05.00.016.7%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.04.00.033.3%2.04.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.04.00.033.3%2.04.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Clearside Biomedical Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.322-0.3220%-0.332+3%-0.096-70%-0.032-90%
Book Value Per Share---0.193-0.1930%0.129-250%0.128-251%0.154-225%
Current Ratio--4.4214.4210%8.542-48%5.236-16%5.047-12%
Debt To Asset Ratio--1.4681.4680%0.793+85%0.701+109%0.662+122%
Debt To Equity Ratio----0%3.837-100%1.314-100%1.240-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--33640163.20033640163.2000%38771488.072-13%110063113.458-69%100024196.985-66%
Eps---0.395-0.3950%-0.400+1%-0.277-30%-0.399+1%
Ev To Ebitda Ratio--infinfnan%-1.422nan%infnan%infnan%
Ev To Sales Ratio--4.4394.4390%31.717-86%30.143-85%325.631-99%
Free Cash Flow Per Share---0.242-0.2420%-0.165-32%-0.205-15%-0.332+37%
Free Cash Flow To Equity Per Share---0.237-0.2370%0.215-210%-0.030-87%-0.020-92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.939--------
Intrinsic Value_10Y_min---2.519--------
Intrinsic Value_1Y_max---0.034--------
Intrinsic Value_1Y_min---0.219--------
Intrinsic Value_3Y_max--0.301--------
Intrinsic Value_3Y_min---0.692--------
Intrinsic Value_5Y_max--1.122--------
Intrinsic Value_5Y_min---1.196--------
Market Cap56503410.480-41%79635679.20079635679.2000%76260643.272+4%132491017.138-40%121861550.052-35%
Net Profit Margin---3.949-3.9490%-24.828+529%-9.046+129%-467.639+11742%
Operating Margin----0%-22.8160%-7.8110%-467.3150%
Operating Ratio--4.0634.0630%23.970-83%9.454-57%468.851-99%
Pb Ratio-3.855+29%-5.433-5.4330%7.805-170%8.499-164%7.609-171%
Pe Ratio-1.888+29%-2.661-2.6610%-2.513-6%101.167-103%84.155-103%
Price Per Share0.745-41%1.0501.0500%1.006+4%1.747-40%1.607-35%
Price To Free Cash Flow Ratio-3.080+29%-4.341-4.3410%-6.082+40%-9.433+117%-8.017+85%
Price To Total Gains Ratio-2.313+29%-3.260-3.2600%-3.025-7%-14.776+353%-11.787+262%
Quick Ratio--0.0250.0250%-+100%0.436-94%0.886-97%
Return On Assets---0.955-0.9550%-0.642-33%-0.736-23%-0.926-3%
Return On Equity----0%-3.1060%-1.5860%-1.9060%
Total Gains Per Share---0.322-0.3220%-0.332+3%-0.096-70%-0.032-90%
Usd Book Value---15911404.891-15911404.8910%10606603.298-250%10517606.627-251%12701191.624-225%
Usd Book Value Change Per Share---0.350-0.3500%-0.361+3%-0.104-70%-0.035-90%
Usd Book Value Per Share---0.210-0.2100%0.140-250%0.139-251%0.167-225%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--36516397.15436516397.1540%42086450.302-13%119473509.658-69%108576265.828-66%
Usd Eps---0.428-0.4280%-0.434+1%-0.301-30%-0.433+1%
Usd Free Cash Flow---19911255.291-19911255.2910%-13610490.949-32%-16904167.760-15%-27300978.905+37%
Usd Free Cash Flow Per Share---0.263-0.2630%-0.179-32%-0.223-15%-0.360+37%
Usd Free Cash Flow To Equity Per Share---0.257-0.2570%0.234-210%-0.033-87%-0.022-92%
Usd Market Cap61334452.076-41%86444529.77286444529.7720%82780928.272+4%143818999.103-40%132280712.581-35%
Usd Price Per Share0.809-41%1.1401.1400%1.091+4%1.896-40%1.744-35%
Usd Profit---32483785.061-32483785.0610%-32945767.782+1%-22806347.011-30%-32807772.943+1%
Usd Revenue--8225692.3488225692.3480%1326950.370+520%9838632.021-16%8203859.831+0%
Usd Total Gains Per Share---0.350-0.3500%-0.361+3%-0.104-70%-0.035-90%
 EOD+2 -6MRQTTM+0 -0YOY+17 -175Y+7 -2710Y+14 -20

3.3 Fundamental Score

Let's check the fundamental score of Clearside Biomedical Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.888
Price to Book Ratio (EOD)Between0-1-3.855
Net Profit Margin (MRQ)Greater than0-3.949
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.025
Current Ratio (MRQ)Greater than14.421
Debt to Asset Ratio (MRQ)Less than11.468
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.955
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Clearside Biomedical Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.785
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Clearside Biomedical Inc.

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Fundamental data was last updated by Penke on 2025-03-11 20:17:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Clearside Biomedical Inc. earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Clearside Biomedical Inc. to the Biotechnology industry mean.
  • A Net Profit Margin of -394.9% means that €-3.95 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clearside Biomedical Inc.:

  • The MRQ is -394.9%. The company is making a huge loss. -2
  • The TTM is -394.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-394.9%TTM-394.9%0.0%
TTM-394.9%YOY-2,482.8%+2,087.9%
TTM-394.9%5Y-904.6%+509.7%
5Y-904.6%10Y-46,763.9%+45,859.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-394.9%-98.5%-296.4%
TTM-394.9%-193.8%-201.1%
YOY-2,482.8%-201.8%-2,281.0%
5Y-904.6%-336.9%-567.7%
10Y-46,763.9%-483.4%-46,280.5%
4.3.1.2. Return on Assets

Shows how efficient Clearside Biomedical Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clearside Biomedical Inc. to the Biotechnology industry mean.
  • -95.5% Return on Assets means that Clearside Biomedical Inc. generated €-0.95 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clearside Biomedical Inc.:

  • The MRQ is -95.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -95.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-95.5%TTM-95.5%0.0%
TTM-95.5%YOY-64.2%-31.3%
TTM-95.5%5Y-73.6%-21.9%
5Y-73.6%10Y-92.6%+19.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-95.5%-12.4%-83.1%
TTM-95.5%-12.3%-83.2%
YOY-64.2%-11.8%-52.4%
5Y-73.6%-13.2%-60.4%
10Y-92.6%-15.1%-77.5%
4.3.1.3. Return on Equity

Shows how efficient Clearside Biomedical Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clearside Biomedical Inc. to the Biotechnology industry mean.
  • 0.0% Return on Equity means Clearside Biomedical Inc. generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clearside Biomedical Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-310.6%+310.6%
TTM-5Y-158.6%+158.6%
5Y-158.6%10Y-190.6%+32.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.0%+16.0%
TTM--16.5%+16.5%
YOY-310.6%-15.2%-295.4%
5Y-158.6%-18.9%-139.7%
10Y-190.6%-20.4%-170.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Clearside Biomedical Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Clearside Biomedical Inc. is operating .

  • Measures how much profit Clearside Biomedical Inc. makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clearside Biomedical Inc. to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clearside Biomedical Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,281.6%+2,281.6%
TTM-5Y-781.1%+781.1%
5Y-781.1%10Y-46,731.5%+45,950.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM--292.1%+292.1%
YOY-2,281.6%-208.2%-2,073.4%
5Y-781.1%-367.9%-413.2%
10Y-46,731.5%-480.8%-46,250.7%
4.3.2.2. Operating Ratio

Measures how efficient Clearside Biomedical Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.06 means that the operating costs are €4.06 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Clearside Biomedical Inc.:

  • The MRQ is 4.063. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.063. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.063TTM4.0630.000
TTM4.063YOY23.970-19.907
TTM4.0635Y9.454-5.391
5Y9.45410Y468.851-459.396
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0632.073+1.990
TTM4.0633.080+0.983
YOY23.9703.231+20.739
5Y9.4544.681+4.773
10Y468.8516.408+462.443
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Clearside Biomedical Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Clearside Biomedical Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.42 means the company has €4.42 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Clearside Biomedical Inc.:

  • The MRQ is 4.421. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.421. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.421TTM4.4210.000
TTM4.421YOY8.542-4.121
TTM4.4215Y5.236-0.815
5Y5.23610Y5.047+0.189
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4213.608+0.813
TTM4.4213.860+0.561
YOY8.5424.489+4.053
5Y5.2365.975-0.739
10Y5.0476.291-1.244
4.4.3.2. Quick Ratio

Measures if Clearside Biomedical Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clearside Biomedical Inc. to the Biotechnology industry mean.
  • A Quick Ratio of 0.02 means the company can pay off €0.02 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clearside Biomedical Inc.:

  • The MRQ is 0.025. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.025. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.025TTM0.0250.000
TTM0.025YOY-+0.025
TTM0.0255Y0.436-0.411
5Y0.43610Y0.886-0.450
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0253.013-2.988
TTM0.0253.293-3.268
YOY-4.370-4.370
5Y0.4365.939-5.503
10Y0.8866.497-5.611
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Clearside Biomedical Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Clearside Biomedical Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clearside Biomedical Inc. to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.47 means that Clearside Biomedical Inc. assets are financed with 146.8% credit (debt) and the remaining percentage (100% - 146.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clearside Biomedical Inc.:

  • The MRQ is 1.468. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.468. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.468TTM1.4680.000
TTM1.468YOY0.793+0.675
TTM1.4685Y0.701+0.767
5Y0.70110Y0.662+0.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4680.340+1.128
TTM1.4680.340+1.128
YOY0.7930.310+0.483
5Y0.7010.363+0.338
10Y0.6620.383+0.279
4.5.4.2. Debt to Equity Ratio

Measures if Clearside Biomedical Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clearside Biomedical Inc. to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clearside Biomedical Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.837-3.837
TTM-5Y1.314-1.314
5Y1.31410Y1.240+0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.387-0.387
TTM-0.426-0.426
YOY3.8370.393+3.444
5Y1.3140.451+0.863
10Y1.2400.495+0.745
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Clearside Biomedical Inc. generates.

  • Above 15 is considered overpriced but always compare Clearside Biomedical Inc. to the Biotechnology industry mean.
  • A PE ratio of -2.66 means the investor is paying €-2.66 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clearside Biomedical Inc.:

  • The EOD is -1.888. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.661. Based on the earnings, the company is expensive. -2
  • The TTM is -2.661. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.888MRQ-2.661+0.773
MRQ-2.661TTM-2.6610.000
TTM-2.661YOY-2.513-0.149
TTM-2.6615Y101.167-103.828
5Y101.16710Y84.155+17.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.888-2.056+0.168
MRQ-2.661-2.642-0.019
TTM-2.661-3.222+0.561
YOY-2.513-3.410+0.897
5Y101.167-6.368+107.535
10Y84.155-6.851+91.006
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clearside Biomedical Inc.:

  • The EOD is -3.080. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.341. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.341. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.080MRQ-4.341+1.261
MRQ-4.341TTM-4.3410.000
TTM-4.341YOY-6.082+1.741
TTM-4.3415Y-9.433+5.091
5Y-9.43310Y-8.017-1.415
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.080-2.929-0.151
MRQ-4.341-3.602-0.739
TTM-4.341-3.891-0.450
YOY-6.082-4.295-1.787
5Y-9.433-8.482-0.951
10Y-8.017-9.279+1.262
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Clearside Biomedical Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -5.43 means the investor is paying €-5.43 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Clearside Biomedical Inc.:

  • The EOD is -3.855. Based on the equity, the company is expensive. -2
  • The MRQ is -5.433. Based on the equity, the company is expensive. -2
  • The TTM is -5.433. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.855MRQ-5.433+1.578
MRQ-5.433TTM-5.4330.000
TTM-5.433YOY7.805-13.238
TTM-5.4335Y8.499-13.932
5Y8.49910Y7.609+0.890
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.8551.880-5.735
MRQ-5.4332.163-7.596
TTM-5.4332.391-7.824
YOY7.8052.433+5.372
5Y8.4993.843+4.656
10Y7.6094.569+3.040
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Total Stockholder Equity 10,278-2,2058,07226,91034,983-25,2119,771-24,429-14,658
Net Invested Capital  15,024-6,0388,98525,99734,983-25,2119,771-24,429-14,658



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets34,018
Total Liabilities49,930
Total Stockholder Equity-15,912
 As reported
Total Liabilities 49,930
Total Stockholder Equity+ -15,912
Total Assets = 34,018

Assets

Total Assets34,018
Total Current Assets30,123
Long-term Assets3,895
Total Current Assets
Cash And Cash Equivalents 28,920
Net Receivables 170
Other Current Assets 311
Total Current Assets  (as reported)30,123
Total Current Assets  (calculated)29,401
+/- 722
Long-term Assets
Property Plant Equipment 3,865
Long-term Assets Other 30
Long-term Assets  (as reported)3,895
Long-term Assets  (calculated)3,895
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,813
Long-term Liabilities43,117
Total Stockholder Equity-15,912
Total Current Liabilities
Accounts payable 2,205
Total Current Liabilities  (as reported)6,813
Total Current Liabilities  (calculated)2,205
+/- 4,608
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,013
Long-term Liabilities Other 42,468
Long-term Liabilities  (as reported)43,117
Long-term Liabilities  (calculated)43,481
+/- 364
Total Stockholder Equity
Total Stockholder Equity (as reported)-15,912
Total Stockholder Equity (calculated)0
+/- 15,912
Other
Capital Stock63
Common Stock Shares Outstanding 62,851
Net Invested Capital -15,912
Net Working Capital 23,310
Property Plant and Equipment Gross 4,785



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
44,120
26,776
19,322
42,903
51,303
34,018
34,01851,30342,90319,32226,77644,120
   > Total Current Assets 
42,944
25,219
18,118
42,136
49,401
30,123
30,12349,40142,13618,11825,21942,944
       Cash And Cash Equivalents 
8,043
22,595
17,287
30,436
48,258
28,920
28,92048,25830,43617,28722,5958,043
       Short-term Investments 
32,835
0
0
0
0
0
0000032,835
       Net Receivables 
0
0
0
10,000
0
170
170010,000000
       Other Current Assets 
17
1,485
109
779
439
311
3114397791091,48517
   > Long-term Assets 
1,176
1,557
1,204
767
3,045
3,895
3,8953,0457671,2041,5571,176
       Property Plant Equipment 
790
1,197
944
607
1,872
3,865
3,8651,8726079441,197790
       Other Assets 
386
360
260
160
30
0
030160260360386
> Total Liabilities 
20,500
15,619
10,559
4,928
40,696
49,930
49,93040,6964,92810,55915,61920,500
   > Total Current Liabilities 
10,476
10,903
9,943
4,640
5,783
6,813
6,8135,7834,6409,94310,90310,476
       Short Long Term Debt 
556
1,333
991
0
0
0
0009911,333556
       Accounts payable 
6,869
1,280
1,997
941
1,050
2,205
2,2051,0509411,9971,2806,869
       Other Current Liabilities 
128
5,000
5,000
0
205
0
020505,0005,000128
   > Long-term Liabilities 
10,024
4,716
616
288
33,977
43,117
43,11733,9772886164,71610,024
       Long term Debt 
9,419
3,819
0
0
0
0
00003,8199,419
       Capital Lease Obligations Min Short Term Debt
0
1,257
989
675
1,285
1,013
1,0131,2856759891,2570
       Other Liabilities 
605
10,467
0
0
33,977
0
033,9770010,467605
       Long-term Liabilities Other 
0
0
0
0
33,977
42,468
42,46833,9770000
> Total Stockholder Equity
23,620
11,157
8,763
37,975
10,607
-15,912
-15,91210,60737,9758,76311,15723,620
   Common Stock
32
44
52
60
61
0
06160524432
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue8,226
Cost of Revenue-355
Gross Profit7,8717,871
 
Operating Income (+$)
Gross Profit7,871
Operating Expense-33,070
Operating Income-24,844-25,199
 
Operating Expense (+$)
Research Development20,846
Selling General Administrative11,869
Selling And Marketing Expenses0
Operating Expense33,07032,715
 
Net Interest Income (+$)
Interest Income0
Interest Expense-9,360
Other Finance Cost-0
Net Interest Income-9,360
 
Pretax Income (+$)
Operating Income-24,844
Net Interest Income-9,360
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-32,485-26,563
EBIT - interestExpense = -9,360
-32,485
-23,125
Interest Expense9,360
Earnings Before Interest and Taxes (EBIT)0-23,125
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-32,485
Tax Provision-0
Net Income From Continuing Ops-32,485-32,485
Net Income-32,485
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,7199,360
 

Technical Analysis of Clearside Biomedical Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clearside Biomedical Inc.. The general trend of Clearside Biomedical Inc. is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clearside Biomedical Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clearside Biomedical Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.925 < 1.14 < 1.19.

The bearish price targets are: 0.725 > 0.615.

Tweet this
Clearside Biomedical Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clearside Biomedical Inc.. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clearside Biomedical Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Moving Average Convergence/Divergence (MACD) ChartClearside Biomedical Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clearside Biomedical Inc.. The current adx is .

Clearside Biomedical Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Relative Strength Index (RSI) ChartClearside Biomedical Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Stochastic Oscillator ChartClearside Biomedical Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Commodity Channel Index (CCI) ChartClearside Biomedical Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Chande Momentum Oscillator (CMO) ChartClearside Biomedical Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Williams %R ChartClearside Biomedical Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Average True Range (ATR) ChartClearside Biomedical Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily On-Balance Volume (OBV) ChartClearside Biomedical Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clearside Biomedical Inc..

Clearside Biomedical Inc. Daily Money Flow Index (MFI) ChartClearside Biomedical Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clearside Biomedical Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Clearside Biomedical Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clearside Biomedical Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.785
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Clearside Biomedical Inc. with someone you think should read this too:
  • Are you bullish or bearish on Clearside Biomedical Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clearside Biomedical Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clearside Biomedical Inc.

I send you an email if I find something interesting about Clearside Biomedical Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Clearside Biomedical Inc..

Receive notifications about Clearside Biomedical Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.